John Burns
Director of Finance/CFO bei SELLAS LIFE SCIENCES GROUP, INC.
Vermögen: 94 352 $ am 31.03.2024
Profil
John T.
Burns is currently the Chief Financial Officer & Accounting Officer, SVP at SELLAS Life Sciences Group, Inc. He previously worked as the Manager-Securities & Exchange Reporting at Pixelworks, Inc. and as the Chief Accounting Officer at Galena Biopharma, Inc. Mr. Burns completed his undergraduate and graduate degrees at Tulane University (Louisiana).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.01.2024 | 93 418 ( 0,17% ) | 94 352 $ | 31.03.2024 |
Aktive Positionen von John Burns
| Unternehmen | Position | Beginn |
|---|---|---|
| SELLAS LIFE SCIENCES GROUP, INC. | Director of Finance/CFO | 30.12.2017 |
Ehemalige bekannte Positionen von John Burns
| Unternehmen | Position | Ende |
|---|---|---|
| PIXELWORKS, INC. | Corporate Officer/Principal | - |
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Comptroller/Controller/Auditor | - |
Ausbildung von John Burns
| Tulane University (Louisiana) | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PIXELWORKS, INC. | Electronic Technology |
| SELLAS LIFE SCIENCES GROUP, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Galena Biopharma, Inc. is a biopharmaceutical company, which develops and commercializes hematology and oncology therapeutics that address unmet medical needs. The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment of the disease to the reduction of its debilitating side effects. Its products include Abstral sublingual tablets and Zuplenz oral soluble film. The company was founded by Craig Mello on April 3, 2006 and is headquartered in San Ramon, CA. | Health Technology |
